Intercept Pharmaceuticals lost nearly 37% last week. It was Todd Hagopian's third largest position, yet his biotech fund was up 2.7% on the week. Here's what Todd thinks of Intercept's news.
from Forbes Real Time https://www.forbes.com/sites/kenkam/2017/09/26/intercept-pharmaceuticals-lost-37-last-week-top-biotech-manager-sells/
via IFTTT
No comments:
Post a Comment